Three‐Year Follow‐Up of the PACI Randomized Controlled Trial (PACI‐ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March
Allergy · 2026-04 · 81 (4) · 1149-1164
DOI: 10.1111/all.70262 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Allergy, online erschienen am 21.02.2026. Verfasst von Kiwako Yamamoto-Hanada und 47 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Dermatitis, Atopic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, JSPS KAKENHI, National Center for Child Health and Development.
Abstract (Originalsprache)
Background
The Prevention of Allergy via Cutaneous Intervention (PACI) randomized controlled trial (RCT) demonstrated that early enhanced topical corticosteroid (TCS) therapy modestly reduced food allergy (FA) at 28 weeks of age. The present prospective follow‐up study (PACI‐ON) evaluated whether these effects persisted to age 3 years.
Methods
Participants were randomized in infancy to early enhanced (proactive) or early conventional (reactive) TCS treatment (1:1) for atopic dermatitis (AD) until 28 weeks. A total of 590 (91%) children who completed the PACI RCT were followed to age 3 years. During follow‐up, no protocolized interventions were given; all participants received usual care. Main outcomes included physician‐diagnosed FA, AD severity (EASI, POEM), sensitization profiles, allergic comorbidities, and growth parameters as safety outcomes.
Results
At age 3 years, the prevalence of any FA remained lower in the early enhanced group than in the conventional group (47.4% vs. 58.8%, p = 0.006), mainly driven by a reduced prevalence of raw egg allergy (30.4% vs. 40.5%, p = 0.013). No between‐group differences were observed for wheeze, asthma, or rhinitis. Japanese cedar sensitization at age 2 was lower in the enhanced group (6.1% vs. 12.2%, p = 0.02 6) but not at age 3. AD control and quality of life were well maintained and similar across groups, with > 90% achieving mild or less disease. Early growth suppression at 1 year resolved by age 3.
Conclusion
Early enhanced AD intervention was associated with a sustained modest reduction in its planned primary follow‐up outcome of FA and safety (growth) up to age 3. Although most differences were small and may reflect early diagnosis and good overall management in both groups, the findings support early AD treatment as a potential strategy to modify allergic disease trajectories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Child Health and Development, Tokyo, Japan.
- Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
- Osaka Habikino Medical Center, Osaka, Japan.
- Kindai University, Faculty of Medicine, Osaka, Japan.
- NHO Sagamihara National Hospital, Kanagawa, Japan.
- Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
ORCID-Profile: Kiwako Yamamoto-Hanada, Mayako Saito-Abe, Fumi Ishikawa, Kenji Toyokuni, Yusuke Inuzuka, Tomoki Yaguchi, Hisako Ogasawara, Mami Shimada, Katsuhito Iikura, Kunihiko Tsuchiya, Risa Tamagawa-Mineoka, Norito Katoh, Makoto Kameda, Yuri Takaoka, Yutaka Takemura, Sakura Sato, Motohiro Ebisawa, Takaaki Itonaga, Shunji Hasegawa, Hiroyuki Wakiguchi, Takao Fujisawa, Fumiya Yamaide, Taiji Nakano, Osamu Natsume, Yasuto Kondo, Yuji Mori, Takahiro Kawaguchi, Masaki Futamura, Kazumitsu Sugiura, Masashi Akiyama, Michihiro Kono, Kyongsun Pak, Tatsuki Fukuie, Tohru Kobayashi, Hirohisa Saito, Hywel C Williams, Yukihiro Ohya
Förderung
- Japan Agency for Medical Research and Development
- JSPS KAKENHI
- National Center for Child Health and Development
Zitieren
APA
Yamamoto-Hanada, K., Saito-Abe, M., Sato, M., Ishikawa, F., Toyokuni, K., Inuzuka, Y., Yaguchi, T., Ogasawara, H., Shimada, M., Kabashima, S., Iikura, K., Tsuchiya, K., Morimoto, M., Tamagawa-Mineoka, R., Masuda, K., Hosoi, H., Katoh, N., Kameda, M., Takaoka, Y., …, & Ohya, Y. (2026). Three‐Year Follow‐Up of the PACI Randomized Controlled Trial (PACI‐ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March. Allergy, 81(4), 1149-1164. https://doi.org/10.1111/all.70262
Vancouver
Yamamoto-Hanada K, Saito-Abe M, Sato M, Ishikawa F, Toyokuni K, Inuzuka Y, et al. Three‐Year Follow‐Up of the PACI Randomized Controlled Trial (PACI‐ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March. Allergy. 2026;81(4):1149-1164. doi:10.1111/all.70262
BibTeX
@article{YamamotoHanada2026,
author = {Yamamoto-Hanada, Kiwako and Saito-Abe, Mayako and Sato, Miori and Ishikawa, Fumi and Toyokuni, Kenji and Inuzuka, Yusuke and Yaguchi, Tomoki and Ogasawara, Hisako and Shimada, Mami and Kabashima, Shigenori and Iikura, Katsuhito and Tsuchiya, Kunihiko and Morimoto, Mariko and Tamagawa-Mineoka, Risa and Masuda, Koji and Hosoi, Hajime and Katoh, Norito and Kameda, Makoto and Takaoka, Yuri and Shigekawa, Amane and Takemura, Yutaka and Xu, Alexandre and Sato, Sakura and Ebisawa, Motohiro and Itonaga, Takaaki and Hasegawa, Shunji and Wakiguchi, Hiroyuki and Fujisawa, Takao and Kanai, Rei and Yamaide, Fumiya and Nakano, Taiji and Natsume, Osamu and Yasuoka, Ryuhei and Kondo, Yasuto and Mori, Yuji and Kawaguchi, Takahiro and Futamura, Masaki and Sugiura, Kazumitsu and Kitazawa, Hiroshi and Hamahata, Yuko and Akiyama, Masashi and Kono, Michihiro and Pak, Kyongsun and Fukuie, Tatsuki and Kobayashi, Tohru and Saito, Hirohisa and Williams, Hywel C and Ohya, Yukihiro},
title = {Three‐Year Follow‐Up of the PACI Randomized Controlled Trial (PACI‐ON): Effects of Early Intervention for Atopic Dermatitis on Atopic March},
journal = {Allergy},
year = {2026},
volume = {81},
number = {4},
pages = {1149--1164},
doi = {10.1111/all.70262}
}
EUVIMED